Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica.

Launched by SALOME KRISTENSEN · Aug 21, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the risk of developing diabetes in patients who have giant cell arteritis (GCA) and polymyalgia rheumatica (PMR). These conditions are types of inflammation in the blood vessels and muscles that can cause pain and fatigue. The researchers want to understand how treatments, particularly glucocorticoids (a type of steroid medication), might affect the likelihood of getting diabetes or worsening existing diabetes in these patients. They will also look for certain signs in blood tests that might help predict who is at greater risk.

To participate, you need to be between 50 and 85 years old, diagnosed with GCA or PMR, and able to understand and speak Danish. If you join the study, you will visit your rheumatology clinic regularly and provide blood samples at certain times. The study is currently recruiting participants, and there's no exclusion criteria, meaning almost anyone who meets the age and diagnosis requirements can take part. This research could help improve care for patients with these conditions by identifying those at higher risk for diabetes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men or women aged 50 to 85 years
• • Are diagnosed with GCA or PMR
• • Diagnosis is established by or confirmed by a rheumatologist (clinical expert opinion)
• • Speak and understand Danish
• • Are able to give signed and dated informed consent
• Exclusion Criteria:
• • None